Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib

Kinetic mechanisms of covalent inhibition - ScienceDirect

Pharmaceuticals, Free Full-Text

Frontiers Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia

Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitors - RSC Chemical Biology (RSC Publishing) DOI:10.1039/D0CB00033G

Frontiers Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia

Pharmaceuticals, Free Full-Text

Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib

Development of covalent inhibitors: Principle, design, and application in cancer - Zheng - 2023 - MedComm – Oncology - Wiley Online Library

Haematologica, Volume 108, Issue 1 by Haematologica - Issuu

Case Study - COVALfinder to Study Irreversible EGFR Drugs

PDF] Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib

Full article: Drug delivery targets and strategies to address mast cell diseases

Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors. - Abstract - Europe PMC